Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration (Clinical Pharmacokinetics, (2025), 10.1007/s40262-025-01565-6)
Publication date
2025-11-28
Authors
Zhao, Q.
Jongsma, M. M.E.
Vuijk, S. A.
de Winter, B. C.M.
Martinez-Vinson, C.
Kolho, K. L.
Norsa, Lorenzo
Hussey, S.
Wine, Eytan
Cohen, Shlomi
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
cc_by_nc
Abstract
In this article the author’s name Victorien M. Wolters was incorrectly written without the mid-initial as Victorien Wolters. The original article has been corrected.
Keywords
Pharmacology, Pharmacology (medical)
Citation
Zhao, Q, Jongsma, M M E, Vuijk, S A, de Winter, B C M, Martinez-Vinson, C, Kolho, K L, Norsa, L, Hussey, S, Wine, E, Cohen, S, Shouval, D S, Assa, A, Lev-Tzion, R, de Meij, T, Wolters, V M, Huynh, H Q, Preijers, T & de Ridder, L 2025, 'Correction : Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration (Clinical Pharmacokinetics, (2025), 10.1007/s40262-025-01565-6)', Clinical Pharmacokinetics, vol. 65, no. 1, pp. 167. https://doi.org/10.1007/s40262-025-01599-w